Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
23.59
-0.12 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
23.40
-0.19 (-0.81%)
After-hours: Dec 5, 2025, 5:20 PM EST
Edgewise Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$35.89
Upside
+52.14%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $33 → $34 | Buy | Maintains | $33 → $34 | +44.13% | Nov 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $49 → $50 | Buy | Maintains | $49 → $50 | +111.95% | Nov 7, 2025 |
| Wedbush | Wedbush | Buy Maintains $35 → $32 | Buy | Maintains | $35 → $32 | +35.65% | Nov 7, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $20 | Hold | Initiates | $20 | -15.22% | Sep 25, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $40 → $30 | Buy | Maintains | $40 → $30 | +27.17% | Aug 19, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $48 → $49 | Buy | Maintains | $48 → $49 | +107.72% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +78.04% | Jun 30, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $48 | Buy | Reiterates | $48 | +103.48% | Jun 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $45 → $40 | Buy | Maintains | $45 → $40 | +69.56% | May 16, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $52 → $48 | Buy | Maintains | $52 → $48 | +103.48% | May 9, 2025 |
| Wedbush | Wedbush | Buy Maintains $43 | Buy | Maintains | $43 | +82.28% | Apr 21, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $56 → $52 | Buy | Maintains | $56 → $52 | +120.43% | Apr 3, 2025 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $50 → $14 | Buy → Hold | Downgrades | $50 → $14 | -40.65% | Apr 3, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $51 | Buy | Maintains | $51 | +116.19% | Apr 2, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +111.95% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $56 | Buy | Reiterates | $56 | +137.39% | Mar 4, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.